Hydrochloric Acid → HCID 67341170, compound
Reaction equation
C([N:8]1[C@@H:13]([CH3:14])[CH2:12][N:11]([C:15]2[CH:16]=[CH:17][C:18]3[N:19]([C:21]([C:24]([F:27])([F:26])[F:25])=[N:22][N:23]=3)[N:20]=2)[C@H:10]([CH3:28])[CH2:9]1)C1C=CC=CC=1.Cl>C(O)C.[Pd]>[CH3:28][C@@H:10]1[CH2:9][NH:8][C@@H:13]([CH3:14])[CH2:12][N:11]1[C:15]1[CH:16]=[CH:17][C:18]2[N:19]([C:21]([C:24]([F:27])([F:26])[F:25])=[N:22][N:23]=2)[N:20]=1Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 2
Procedure
A solution of 6-[(2R,5S)-4-benzyl-2,5-dimethylpiperazin-1-yl]-3-(trifluoromethyl)[1,2,4]triazolo[4,3-b]pyridazine (6.1 g, 15.62 mmol) in ethanol (150 mL) and 5M hydrochloric acid (9.37 mL, 46.87 mmol) was hydrogenated over 10% palladium on charcoal (1 g, 9.40 mmol) under hydrogen at 1 atmosphere for 3 days. The catalyst was filtered off and the filtrate was evaporated. The residue was taken into DCM and washed with 2M aqueous K2CO3. The organic phase was dried over MgSO4 and evaporated. The crude product was purified by MPLC silica chromatography, elution gradient 2 to 5% methanolic ammonia in DCM. Product fractions were evaporated to near dryness and crystallised from ether to afford 6-[(2R,5S)-2,5-dimethylpiperazin-1-yl]-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-b]pyridazine (1.430 g, 30.5%) as a white crystalline solid.
Workup
- filtrationThe catalyst was filtered off
- customthe filtrate was evaporated
- washwashed with 2M aqueous K2CO3
- dry with materialThe organic phase was dried over MgSO4
- customevaporated
- customThe crude product was purified by MPLC silica chromatography, elution gradient 2 to 5% methanolic ammonia in DCM
- customProduct fractions were evaporated
- customcrystallised from ether
Sources & evidence
- ORD record
- ord-a89b86e21474448484944952c3b09ba7
- Source dataset
- uspto-grants-2011_08
- Patent number
- US08003649B2
Reaction notes
Loading…